GLP-1 and GIP inhibitors are amazing medications at doing what they were developed for managing blood sugar in people with type 2 diabetes and weight loss in obesity, study co-author Kelly Allison, a professor of psychiatry and director of the Center for Weight and Eating Disorders at Penn, said in the news release
As access to these innovative medications increases, so will the prevalence of their potential adverse events
When Semaglutide activates GLP-1 receptors in the brain, it sends signals that help you feel full sooner and stay satisfied longer
Lifestyle factors that support cognitive health include regular physical activity, which improves cerebral blood flow and may enhance neuroplasticity
Stay hydrated, listen to your body, and remember that the best wellness approach is the one that works sustainably for your unique life and circumstances.
Adipose tissue fibrosis: the unwanted houseguest invited by obesity